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Extracorporeal formation of mineralized bone-like tissue is still an unsolved challenge in tissue engineering.
Embryonic stem cells may open up new therapeutic options for the future and should be an interesting model for
the analysis of fetal organogenesis. Here we describe a technique for culturing embryonic stem cells (ESCs) in the
absence of artificial scaffolds which generated mineralized miromasses. Embryonic stem cells were harvested and
osteogenic differentiation was stimulated by the addition of dexamethasone, ascorbic acid, and ß-
glycerolphosphate (DAG). After three days of cultivation microspheres were formed. These spherical three-
dimensional cell units showed a peripheral zone consisting of densely packed cell layers surrounded by minerals
that were embedded in the extracellular matrix. Alizarine red staining confirmed evidence of mineralization after 10
days of DAG stimulation in the stimulated but not in the control group. Transmission electron microscopy
demonstrated scorching crystallites and collagenous fibrils as early indication of bone formation. These extracellular
structures resembled hydroxyl apatite-like crystals as demonstrated by distinct diffraction patterns using electron
diffraction analysis. The micromass culture technique is an appropriate model to form three-dimensional bone-like
micro-units without the need for an underlying scaffold. Further studies will have to show whether the technique
is applicable also to pluripotent stem cells of different origin.
Keywords: Embryonal stem cell, osteogenic tissue engineering, three-dimensional culture technique, scaffold free
tissue, hydroxyl apatite
Introduction
Bony defects have various causes and often turn out to
be a major therapeutic challenge. Until today, the recon-
struction of bone using autologous grafts has been
recognized as the gold standard because it provides bio-
logical active cells with osteoinductive properties and
avoids any immunological reactions [1]. Unfortunately,
the harvesting of these grafts causes donor-side defects
and shows a quantitative limitation [2-4]. Artificial
materials and extracorporeal tissue formation are alter-
native approaches for the reconstruction of bone defects,
because they neither cause donor-site lesions nor is their
availabilty restricted.
Bone is a highly specialized tissue of the organism
which is generated by mineralization of the extracellular
matrix called osteoid. Osteoblasts and osteoclasts contri-
bute to the formation and remodelling of bone tissue.
However, there are further cell types e.g. endothelia
cells, which are also essential for bone formation [5].
The complex cell-driven process of bone formation
starts early in the embryo and results in bone tissue
with unique features that combines stiffness and elasti-
city with the ability to regenerate itself [6]. A key feature
of bone tissue is the presence of biological active apatite
crystals. These crystals were formatted by the minerali-
zation of the extracellular matrix (osteoid) with calcium
and phosphate ions. The process of mineralization can
be monitored histologically by special stainings like ali-
zarin red or ultrastructurally by transmission (TEM) and
scanning electron microscopy (SEM).
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usually based on a combination of cells and scaffolds
[7-9]. Even the ex vivo de novo bone building starts
with the secretion of collagen via matrix vesicles fol-
lowed by the mineralisation of the extracellular matrix
molecules [7]. It has been reported that cells in three-
dimensional cultures exert higher proliferation rates
than cells cultured in monolayers, suggesting that their
differentiation resembles more closely that seen in situ
[10-12]. Furthermore, it is assumed that cells are more
flexible to change their shape and behaviour upon speci-
fic cell signals when they are cultured in three-dimen-
sional as compared to two-dimensional cultures [13,14].
Whereas a multitude of extracorporeal bone tissue
engineering approaches have been undertaken to fabri-
cate bone tissue ex vivo, up to now cell culture-based
methods for synthesizing bone-like tissue on a structural
level are still limited due to technical restrictions [15].
Here we describe that mineralized bone-like matrix is
produced by osteoinduced totipotent embryonic stem
cells cultured in three-dimensional micromass technique
in the absence of any scaffold. The osteogenic differen-
tiation of the cells was induced by the addition of dexa-
methasone, ascorbic acid, and ß-glycerolphosphate
(DAG) to the medium [16,17]. The features of ossifica-
tion mimic in-vivo bone formation, thus enabling
matured mineralized bone matrix to be generated.
Materials and methods
Cell culture
A cell culture method for producing mineralized bioma-
terial-free, three-dimensional cell units up to 0.4 mm in
diameter was established. Feeder-independent murine
embryonic stem cells (ESCs) were kindly provided by K.
Pfeffer (Institute for Microbiology, Heinrich Heine Uni-
versity of Düsseldorf, Germany). The cells were derived
from the inner cell mass of blastocysts extracted from
C57BL/6 mice and tested positive for the stem cell mar-
kers Pouf1 (alias Oct4) and Foxd3 [18]. Cells were cul-
tured in Dulbecco’s modified Eagle medium (DMEM,
Gibco) supplemented with penicillin (100 U/ml, Grü-
nenthal), streptomycin (100 U/ml, Hefa-pharma), 2-mer-
captoethanol (500 mM, Gibco), ultraglutamine (2 mM;
Cambrex), leukemia inhibitor factor (1000 U/ml; Chemi-
con) and 15% fetal calf serum. The cells were split every
second day and the medium was changed every day by
detaching the cells with 0.25% trypsin (Pan Biotech).
ESCs were detached from the plate, centrifuged and
resuspended in normal growth medium (1 × 106 cells/
ml).
To prevent adherence of the cells leading to the for-
mation of monolayers, the microsphere assembly bior-
eactor was prepared by filling 60 μlo fas o l u t i o n
consisting of 2% agarose in DMEM (without any
supplements) into 96-well plates. After curing of the
agarose solution to each well, 180 μlo fc e l ls u s p e n s i o n
was added and the cells were incubated overnight. The
old medium was replaced by equal volumes (160 μl) of
control medium and control medium containing 100
nM dexamethasone, 50 μM ascorbic acid, and 10 mM
b-glyerolphosphate (all from Sigma), respectivey. Thus,
half of the culture chambers were incubated in the pre-
sence of dexamethasone, ascorbic acid, and DAG, (DAG
(+)) to induce the osteogenic differentiation, while the
other half used as a control was cultivated in medium
without these stimuli (DAG (-)). Both cell populations
were kept in culture for three weeks in an incubator
under a humified atmosphere (37°C, 90% humidity, 5%
CO2). The medium was changed every day. After 3, 7,
10, and 21 days one quarter of the cultivated wells with
microspheres of the + and - DAG group was harvested
and transferred into Petri dishes for a washing step with
phosphate-buffered saline (PBS). Subsequently the pre-
paration of the spheres for the different analysis was
performed.
Histological analysis
For histologiacal analysis, micromasses were fixed in for-
malin (4%) until further procession. Formaline-fixed
microspheres were dehydrated in increasing ethanol
concentrations (50%, 75%, 90% and 100%) and
embedded in paraffin (Paraplast plus). Sections (4 μm)
were mounted on Superfrost slides, deparaffinized with
xylol and rehydrated in decreasing ethanol concentra-
tions. Samples were stained with alizarine red solution
(2%) to detect calcium and counterstained with toluidine
blue, as mentioned in the literature. Briefly, after stain-
ing with toludine blue the slides were counterstained
with alizarin red (mixture of 0.5 g alizarin red and 0.5
ml 0.28% NH3 with 45 ml distilled water (pH: 6.4)).
Before the slides were finally covered with entellan, they
were incubated in xylene. A descriptive analysis was
performed.
Scanning electron microscopy
For scanning electron microscopy, micromasses were
f i x e di ng l u t a r a l d e h y d e( 4 % )f o l l o w e db yaw a s h i n gs t e p
with 0.1 M PBS. Microspheres were dehydrated in
increasing isopropanol concentrations (30%, 50%, 70%,
90%, 96%, and 100%; 30 minutes for each concentra-
tion). The critical pont drying was performed following
the instructors protocol. In this procedure isopropanol
was substituted for CO2 by five washing steps. After
drying, the specimens were directly put on a carbon pad
of a SEM-holder (Cambridge). For morphological stu-
dies, probes were sputtered with platinum, whereas for
EDX analysis, samples were coated with carbon using
standard techniques. Scanning electron microscopy was
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acceleration voltage of 5-15 kV.
Transmission electron microscopy
For TEM, specimens were fixated in glutaraldehyde
(2.5%) and embedded in araldite. For morphological
analysis, a fixation with osmium tetroxide and glutaral-
dehyde was carried out. Specimens were washed three
times with 0.1 M PBS for 10 minutes each. Micro-
spheres were dehydrated in increasing isopropanol con-
centrations (50%, 70%, 90%, 96% and 100%; 30 minutes
for each concentration) and followed by a transfer into
propylene oxid. Afterwards the spheres were transferred
to pure araldite by using intermediate ratios of mixtures
(100% propylene oxide, 2/1 propylene oxide/araldite, 1/
1, 1/2, 100% araldite). To harden the araldite the speci-
men were kept at 42°C for 24 hours and afterwards
were sectioned with a microtome (Ultracut S, Reichert).
For morphological studies ultrathin sections were
stained with osmium tetroxide (OsO4). For ultrastruc-
tural assessment of the mineral substance no staining
was performed and the water contact during prepara-
tion, particulary during sectioning, was reduced to a
minimum in order to avoid dissolution or redistribution.
The ultrathin slides were applied to copper grids and
contrasted with uranyl acetate. Analyses were performed
with an acceleration voltage of 80 kV with EM902
(Zeiss). Electron spectroscopic diffraction analysis was
performed with the specimens used for the TEM. Con-
tact time of the slides with water on the microtome was
limited to a few seconds to avoid redistribution of the
crystallites. Analyses were performed with an EM902
(Zeiss) microscopy using 80 kV acceleration voltage and
a camera length of 650 mm. D-values for the 002 dif-
fraction patterns were calculated according to Arnold et
al. and Plate et al. [19,20].
Results
After three days all cell cultures formed spheroid, three-
dimensional cell units in high density (5 × 10
6 cells/ml),
which appeared as oval micromasses. At that time,
neither in specimens from the DAGstimulated group
nor in the non-stimulated group signs of mineralization
were detectable. After 10 days of cultivation the first
indications of mineralization were visible in the DAG-
treated cells, while they were absent in non-stimulated
cells. Mineralization proceeded in the centre of the sti-
mulated specimens and became more clearly visible
after 3 weeks of cultivation in the presence of osteoin-
ductive stimuli. Numerous living cells were detected in
the mineralized centre of the spheres by means of tolui-
dine blue staining (Figure 1). Generally, the mineraliza-
tion was most prominent in the centre of the sphere, as
demonstrated in histological sections stained with
alizarin red (Figure 1). The SEM analysis confirmed the
differences regarding the distribution pattern of the
formed mineral and the quantitative differences. The +
DAG group showed an intense mineralization in the
centre of the spheres (Figure 2). Transmission electron
Figure 1 Micromasses consisting of embryonic stem cells were
cultured with or without DAG and stained with toluidine blue
followed by counterstaining with alizarin red. Shown is evidence
for the mineralization in the centre of the micromasses, which were
stained in red.
Figure 2 SEM image of the mineralization in the centre of a
+DAG spheres after 21 days.
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crystallites in the mineralized area, which appeared after
21 days of cultivation (Figure 3a). Theses crystals were
typically embedded in an extracellular matrix containing
numerous collagenous fibrils (Figure 3b). The spherical
cell units had a peripheral zone consisting of densely
packed cell layers, which surrounded the minerals. To
demonstrate that the mineralized matrix in the DAG-
treated group is composed of hydroxyl apatite crystals,
electron spectroscopic diffraction analysis was per-
formed (Figure 4). In accordance with Arnold et al. and
Plate et al., the d-value for the diffraction ring 002 was
calculated (0.344 nm) (Figure 3 and 4).
Discussion
T h ed e - n o v of o r m a t i o no fb o n ei nt e r m so ft i s s u ee n g i -
neering requires cells, matrix and growth factors. For
creating larger tissue constructs for surgical use, natural
or artificial biomaterials are additionally needed as scaf-
folds. However, there is controversy about the use of
biomaterials as a scaffold because the physicochemical
properties of the biomaterials influence the proliferation
and gene expression of the cells [9,21,22]. Even protein
coating of the scaffold has impact on the attachment of
the cells [23-25]. It is generally accepted that no existing
artificial or natural scaffold can meet all the require-
ments for ruling out undesired effects. The micromass
culture technique may be an alternative for substituting
artificial scaffolds. In contrast to monolayers, cell cul-
ture-based techniques in three-dimensional space appear
to more closely resemble in-vivo conditions [11]. It is
well known that many functions of the cells, e.g. differ-
entiation and proliferation, rely on intact cell-cell inter-
actions and a tight attachment to extracellular matrix
components. In micromasses, the cells can interact with
each other and maintain these interactions [26]. Former
studies have shown that in micromass culture techni-
ques a cartilaginous differentiation of ESCs is feasible
[27,28]. In the presented study we show that stimulated
ESCs cultured in micromass technique form minealized
microspheres during cultivation.
Aggregation of cells is the pivotal stage in the develop-
ment of skeletal tissues and the primary resource from
which the skeleton is built and through which the skele-
ton is modified ontogenetically [29]. Mineralized bony
units formed ex vivo seem to be an ideal biomaterial
because they combine the structural features of bone.
Currently, the best treatment option for bone defects
utilises the enhanced regeneration potential of embryo-
nic stem cells [30]. In this respect, fusion of multiple
bony units may allow the reconstruction of larger skele-
tal elements. Through the ability of embryonic stem
cells to differentiate along the whole osteogenic path-
way, embryonic stem cell transplantation may play a
future role in the treatment of generalized bone dis-
eases. Furthermore, we show that osteoinductive stimuli
including DAG support the mineralization of the extra-
cellular matrix and that stimulated micromasses produce
more mineralized extracellular matrix than micromasses
cultured in the absence of these stimuli. To verify that
the matrix consists of hydroxyl apatite, we performed
transmission electron microscopy and revealed a time-
dependent occurrence of scorching crystallites in the
interior of the microspheres. Using electron spectro-
scopic diffraction we confirmed that the crystallites con-
sisted of hydroxyl apatite. Furthermore, we detected
Figure 3 ESC micromass cultured for 21 days in the presence
of medium containing dexamethasone, ascorbic acid, and ß-
glycerolphosphate (DAG). Transmission electron microscopy
demonstrated scorching crystallites (a) and collagen fibrils (b) in the
mineralized area.
Figure 4 Electron spectroscopic diffraction in the centre of
DAG-treated ESC microspheres showed typical patterns for
hydroxyl apatite formation (day 21).
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collagenous fibrils within bone tissue. Collagen I fibrils
are known to be a major extracellular matrix component
of bone tissue [5,31]. Plate and co-workers described the
formation of hydroxyl apatite in bone and dentin as a
multistage process resulting in the deposition of a
mineralized matrix. These calcium-phosphate crystals
coordinate longitudinally and accumulate as scorching
crystallites [20]. In samples from stimulated ESCs we
detected crystal-like structures in the interior of the
microspheres. These ESC microspheres resemble aggre-
gates consisting of preosteoblasts.
Our finding of a mineralization in microspheres of
DAG-treated ESCs seems to share similarity to the for-
mation of bone and dentin in vivo. Thus, it appears that
osteologous differentiation of ESC micromasses may be
a feasible approach to advance the bony reconstruction
of large defects. However, the size of the microspheres
is limited possibly due to restricted diffusion of nutrients
and we are currently unable to format larger tissue con-
structs without support by artificial matrices. The use of
bioreactors may be an adequate technique to gain larger
tissue constructs without the need for a scaffold by sim-
ply transferring osteologously differentiated ECS micro-
masses [32].
Nevertheless, the micromass culture technique may be
an appropriate model to analyse the formation of the
skeleton during embryonic or fetal organogenesis.
Aggregation of cells to a critical size is a fundamental
step in initiating organogenesis of vertebrates [33]. Hall
and Miyake assume that the condensation of cells is a
precondition for skeleton formation that promotes the
differentiation of cells to osteoblasts and chondroblasts
[29,34]. Furthermore, the three-dimensional micromass
culture technique may be a useful method for identify-
ing substances that enhance mineralization.
The use of embryonic stem cells will probably play a
major role in tissue engineering in the future because of
the remakable potential and differentiation capacity of
ESCs. Prior to clinical application, many challenges need
to be faced in future studies, particularly with respect to
immune tolerance and the formation of malignant
tumors in the host organism. However, the studies by
Burt and coworkers are promising with regard to
immuntolerance. They grafted ESCs into MHC-mis-
matched mice and found no clinical or histological evi-
dence for a graft-versus-host or host-versus-graft
reaction [35].
Furthermore, Zavazava has demonstrated that ESCs
have the potential to induce immune tolerance [36] and
revealed evidence for a suppression of the MHC gene
expression [37]. Trounson and colleagues showed that
transplanted undifferentiated ESCs may induce teratoma
and teratocarcinoma [38]. Even if many other authors
could not find any indication of malignant transforma-
tion in their studies [39], the eventuality of cancer
induction is still an argument for the restricted use of
these cells. Lastly, there are legal and ethical restrictions
for the use of human ESCs.
Despite the above mentioned doubts about the use of
ESCs, they may open up new therapeutic options for
future application and may turn out to be interesting
models for the study of fetal organogenesis. Further-
more, the results may be transferred to other pluripo-
tent stem cells, such as umbilical somatic stem cells,
which have not so many restrictions.
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